Hikal Q3 results: Net profit down 38% to Rs 16 crore
Thu, Feb 8, 2024 10:29 PM

Hikal Q3 results: Net profit down 38% to Rs 16 crore

A Flip by Shubhangi Gupta
Get it on Google Play
Pharma and chemicals firm Hikal Ltd on February 8 reported a 38 percent year-on-year fall in consolidated net profit at Rs 16 crore for the October-December quarter of the current financial year. The company reported a profit of Rs 26 crore in the same period of the previous financial year. Revenue came in at Rs 448 crore, down 17 percent from the year-ago quarter of Rs 540 crore.

More great flips

Telangana government sanctions Rs 205 crore for Warangal airport

Telangana government sanctions Rs 205 crore for Warangal airport

The Telangana government has sanctioned Rs 205 crore to acquire 280 acres of land for the development of Mamnoor Airport at Warangal, following a "No Objection" certificate from the GMR Group, which manages Hyderabad Airport. The Airports Authority of India will develop the airport for A-320 type of aircraft, with the state providing additional land free of cost.

Open Flip
Multibagger stock hits 5% upper circuit after delivering 150% returns YTD

Multibagger stock hits 5% upper circuit after delivering 150% returns YTD

Multibagger stock: Shares of Blue Cloud Softech Solutions Limited, a tech-driven company based in Hyderabad, hit the upper circuit limit on Monday, November 18 on the back of impressive Q2FY25 results and key corporate developments. Blue Cloud Softech share price hit its 5 per cent upper circuit at ₹144.20 on the BSE today. The company enjoys a market capitalisation of ₹3,145.59 crore.

Open Flip
SC declines relief to Zydus Lifesciences in breast cancer drug case

SC declines relief to Zydus Lifesciences in breast cancer drug case

The Supreme Court refuses to grant interim relief to Zydus Lifesciences, sending its case against a Delhi High Court injunction back for further deliberation, preventing the manufacture and sale of its breast cancer drug Sigrima due to patent infringement allegations by F. Hoffmann-La Roche. The shares of Zydus Lifescience fell as much as 1.95%.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon